New molecular targets for cholesterol-lowering therapy

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 315-320

  Izzat, Najwa N ^a   Deshazer, Mitchell E ^a   Loose Mitchell, David S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2164 U 90; BILE ACID; BRL 39924 A; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; FENPIPRAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; UNCLASSIFIED DRUG;

BILE ACID SYNTHESIS; CHOLESTEROL BLOOD LEVEL; HYPERLIPIDEMIA; ILEUM; LIPID ABSORPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; HUMANS;

EID: 0034057288     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Azuma Y, Seto J, Ohno K, Mikami H, Yamada T, Yamasaki M, Chiba M and Nobuhara Y (1999) Effects of NTE-122, an acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and lipid secretion from CaCo-2 cells, and cholesterol absorption in rats. Jpn J Pharmacol 80:81-84.
2. Bartram H-P, Scheppach W, Englert S, Dusel G, Richter A, Richter F and Kasper H (1995) Effects of deoxycholic acid and butyrate on mucosal prostaglandin E2 release and cell proliferation in the human sigmoid colon. J Parenter Enterai Nutr 19:182-186.
3. Behbod F and Loose-Mitchell DS (1998) Isolation, expression and characterization of a human ileal sodium-dependent bile acid transporter. Abstract 60, American Gastroenterological Association, DDW, New Orleans, LA.
4. Boffelli D, Weber FE, Compassi S, Werder M, Schulthess G and Hauser H (1997) Reconstitution and further characterization of the cholesterol transport activity of the small-intestinal brush border membrane. Biochemistry 36:10784-10792.
5. Chen J, Cooper AD and Levy-Wilson B (1999) Hepatocyte nuclear factor 1 binds to and transactivates the human but not the rat CYP7A1 promoter. Biochcm Biophys Res Commun 260:829-834.
6. Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH and Dawson PA (1998) Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 274:G157-G169.
7. Dawson PA and Rudel LL (1999) Intestinal cholesterol absorption. Curr Opin Lipidol 10:315-320
8. Earnest DL, Holubec H, Wall RK, Jolley CS, Bissonette M, Bhattacharyya AK, Roy H, Khare S and Brasitus TA (1994) Chemoprevention of azoxymethane-induced colonie carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 54:5071-5074.
9. Endo A (1986) Drugs inhibiting HMG-CoA reductase. Pharmacol Ther 31:257-267.
10. Endo A, Kuroda M and Tsujita Y (1976) ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot 29: 1346-1348.
11. Endo A, Tsujita Y, Kuroda M and Tanzawa K (1977) Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem 77:31-36.
12. Fears R, Brown R, Ferres H, Grenier F and Tyrrell AW (1990) Effects of novel bile salts on cholesterol metabolism in rats and guinea pigs. Biochem Pharmacol 40:2029-2037.
13. Hallen S, Branden M, Dawson PA and Sachs G (1999) Membrane insertion scanning of the human ileal sodium/bile acid co-transporter. Biochemistry 38:11379-11388.
14. Hauser H, Dyer JH, Nandy A, Vega MA, Werder M, Bieliauskaite E, Weber FE, Compassi S, Gemperli A, Boffelli D, Wehrli E, Schulthess G and Phillips MC (1998) Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 37:17843-17850.
15. Hebert PR, Gaziano JM, Chan KS and Hennekens CH (1997) Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. J Am Med Assoc 278:313-321.
16. Heinemann T, Axtmann G and von Bergmann K (1993) Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 23:827-831.
17. Ichihashi T, Izawa M, Miyata K, Mizui T, Hirano K and Takagishi Y (1998) Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption. J Pharmacol Exp Ther 284:43-50.
18. Janowski BA, Willy PJ, Devi TR, Falck JR and Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature (Lond) 383:728-731.
19. Krag E and Phillips SF (1974) Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. J Clin Invest 53:1686-1694.
20. Lee JK, Kim SU and Kim JH (1999) Modification of chitosan to improve its hypocholesterolemic capacity. Biosci Biotechnol Biochem 63:833-839.
21. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su J-L, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA and Willson TM (1997) Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272:3137-3140.
22. Lewis MC, Brieaddy LE and Root C (1995) Effects of 2164U90 on ileal bile acid absorption and serum cholesterol in rats and mice. J Lipid Res 36:1098-1105.
23. Love MW and Dawson PA (1998) New insights into bile acid transport. Curr Opin Lipidol 9:225-229.
24. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ and Shan B (1999) Identification of a nuclear receptor for bile acids. Science (Wash D C) 284:1362-1365.
25. Meier PJ, Eckhardt U, Schroder A, Hagenbuch B and Steiger B (1997) Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 26:1667-1677.
26. Mekjian HS, Phillips SF and Hofmann AF (1971) Colonic secretion of water and electrolytes induced by bile acids: Perfusion studies in man. J Clin Invest 50:1569-1577.
27. Moghadasian MH (1999) Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Life Sci 65:1329-1337.
28. Morehouse LA, Bangerter F-W, DeNinno MP, Inskeep PB, McCarthy PA, Pettini JL, Savoy YE, Sugarman ED, Wilkins RW, Wilson TC, Woody HA, Zaccaro LM and Chandler CB (1999) Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: Evidence for a nonstoichiometric, intestinal mechanism of action. J Lipid Res 40:464-474.
29. Morvay K, Szentleleki K, Torok G, Pinter A, Borzsonyi M and Nawroth R (1989) Effect of change of fecal bile acid excretion achieved by operative procedures on 1,2-dimethylhydrazine-induced colon cancer in rats. Dis Colon Rectum 32:860-863.
30. Oelkers P, Behari A, Cromley D, Billheimer JT and Sturley SL (1998) Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J Biol Chem 273:26765-26771.
31. Ostlund RE, Spillburg CA and Stenson WF (1999) Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans. Am J Clin Nutr 70:826-831.
32. Pandak WM, Li YC, Chiang JY, Studer EJ, Gurley EC, Heuman DM, Vlahcevic ZR and Hylemon PB (1991) Regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by taurocholate and cholesterol in the chronic biliary diverted rat. J Biol Chem 286:3416-3421.
33. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD and Lehmann JM (1999) Bile acids: Natural ligands for an orphan nuclear receptor. Science (Wash D C) 284:1365-1368.
34. Feet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE and Mangelsdorf DJ (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 93:693-704.
35. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L and McCormick LS (1999) Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 341:70-76.
36. Poorman JA, Buck RA, Smith SA, Overturf ML and Loose-Mitchell DS (1993) Bile acid excretion and cholesterol 7α-hydroxylase expression in hypercholesterolemia-resistant rabbits. J Lipid Res 34:1675-1685.
37. Root C, Smith CD, Winegar DA, Brieaddy LE and Lewis MC (1995) Inhibition of ileal sodium-dependent bile acid transport by 2164U90. J Lipid Res 36:1106-1115.
38. Ross SD, Allen IE, Connelly JE, Korenblat BM, Smith ME, Bishop D and Luo D (1999) Clinical outcomes in statin treatment trials: A meta-analysis. Arch Intern Med 159:1793-1802.
39. Salen G, Ahrens EH and Grundy SM (1970) Metabolism of beta-sitosterol in man. J Clin Invest. 49:952-967.
40. Salisbury BG, Davis HR, Burner RE, Burnett DA, Bowkow G, Caplen MA, Clemmons AL, Compton DS, Hoos LM, McGregor DG, Schnitzer-Polokoff R, Smith AA, Weig BC, Zilli DL, Clader JW and Sybertz EJ (1995) Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis 115:45-63.
41. Scandinavian Simvastatin Survival Study Group (1994) Randomised trail of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389.
42. Schulman KA, Kinosian B, Jacobson TA, Glick H, Willian MK, Koffer H and Eisenberg JM (1990) Reducing high blood cholesterol with drugs. Cost-effectiveness of pharmacologic management. J Am Med Assoc 264:3025-3033.
43. Schwarz M, Lund EG and Russell DW (1998) Two 7α-hydroxylase enzymes in bile acid biosynthesis. Curr Opin Lipidol 9:113-118.
44. Shepherd J, Cobbe SM, Packard CJ, Isles CG, Lorimer AR, Macfarlane PW and McKillop JH (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301-1307.
45. Spady DK, Cuthbert JA, Willard MN and Meidell RS (1995) Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest 96:700-709.
46. Spady DK, Cuthbert JA, Willard MN and Meidell RS (1998) Overexpression of cholesterol 7α-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced. J Biol Chem 273:126-132.
47. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II) (1993) J Am Med Assoc 269:3015-3023.
48. The AFCAPS/TexCAPS Research Group (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. J Am Med Assoc 279:1615-1622.
49. The post coronary artery bypass graft trial investigators (1997) The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336:153-162.
50. Uchida T, Aoyama K, Wantanabe T and Higuchi S (1998) Relationship between bioavailabilty and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats. Atherosclerosis 137:97-106.
51. Umeda Y, Hirano T, Kako Y, Kamagata K, Okuyama K and Suzuki K (1998) A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal. Life Sci 63: PL187-PL195.
52. Vlahcevic ZR, Heuman DM and Hylemon PB (1990) Physiology and pathophysiology of enterohepatic circulation of bile acids, in Hepatology: A Textbook of Liver Diseases (Zakim D and Boyer TD eds) pp 341-377, WB Saunders Company, Philadelphia, PA.
53. Vlahcevic ZR, Stravitz RT, Heuman DM, Hylemon PB and Pandak WM (1997) Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. Gastroenterology 113:1949-1957.
54. Wang H, Chen J, Hollister K, Sowers LC and Forman BM (1999) Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3:543-553.
55. Weinman SA, Carruth MW and Dawson PA (1998) Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic. J Biol Chem 273:34691-34695.
56. Wess, G, Kramer, W, Enhsen A, Glombik H, Baringhaus K-H, Boger G, Urmann M, Bock K, Kleine H, Neckermann G, Hoffmann A, Pittius C, Falk E, Fehlhaber H-W, Kogler H and Friedrich M (1994) Specific inhibitors of ileal bile acid transport. J Med Chem 37:873-875.
57. Wong MH, Oelkers P and Dawson PA (1995) Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J Biol Chem 270:27228-27234.
58. Zavacki AM, Lehmann JM, Seol W, Willson TM, Kliewer SA and Moore DD (1997) Activation of the orphan receptor RIP14 by retinoids. Proc Natl Acad Sci USA 94:7909-7914.